-
INTEGRATING SOCIAL DETERMINANTS OF HEALTH INTO GLP-1 VALUE ASSESSMENT: A PROPOSED DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS FRAMEWORK
Feb 25, 2026, 14:42 PM -
PERSONALITY PROFILES AND BURNOUT DIMENSIONS AMONG EMERGENCY CARE PROFESSIONALS IN HUNGARY: A CROSS-SECTIONAL STUDY
Feb 25, 2026, 14:42 PM -
HEALTH-ECONOMIC VALUE OF A NOVEL ANASTOMOSIS PROTECTION DEVICE AFTER COLORECTAL RESECTION: AN ANALYSIS BASED ON THE SAFE-2025 STUDY AND U.S. CLAIMS DATA
Feb 25, 2026, 14:42 PM -
EFFECT OF STATIN USE ON THE RISK OF ADVANCED LIVER DISEASE AND MORTALITY AMONG PATIENTS WITH CHRONIC LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Feb 25, 2026, 14:42 PM -
POST-COVID-19 SMART DEVICE SPECIFICATIONS IN U.S. MEDICAID SECTION 1915(C) WAIVER COVERAGE FOR ASSISTIVE TECHNOLOGIES AND MONITORING SERVICES
Feb 25, 2026, 14:42 PM -
ASSOCIATION BETWEEN INTRA- AND POST-OPERATIVE SURGICAL COMPLICATIONS AND HEALTH ECONOMIC OUTCOMES IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFT: A RETROSPECTIVE DATABASE ANALYSIS
Feb 25, 2026, 14:42 PM -
LABORATORY MARKERS AND SHORT-TERM OUTCOMES IN RESPIRATORY SYNCYTIAL VIRUS AMONG OLDER ADULTS: MEDICARE-ENHANCED AND LABORATORY DATA ANALYSIS 2021-2025
Feb 25, 2026, 14:42 PM -
COST-EFFECTIVENESS ANALYSIS OF GLP-1 RA TO PREVENT TYPE 2 DIABETES AMONG TEENAGERS IN THE UNITED STATES
Feb 25, 2026, 14:42 PM -
VALIDATION EVIDENCE OF HEALTHCARE UTILISATION MEASURES FOR PAEDIATRIC POPULATIONS: A SYSTEMATIC REVIEW
Feb 25, 2026, 14:42 PM -
FUELING FRICTIONS: HOW NIGERIA’S FUEL SUBSIDY REMOVAL RESHAPED HEALTH ACCESS
Feb 25, 2026, 14:42 PM -
RISK OF IMMUNE CHECKPOINT INHIBITOR (ICI) DISCONTINUATION IN OLDER ADULTS WITH MELANOMA, A POPULATION-BASED STUDY
Feb 25, 2026, 14:42 PM -
ECONOMIC OUTCOMES, REAL-WORLD ADHERENCE PATTERNS AND PREDICTIVE MODELING OF MIGRAINE PROPHYLAXIS: A RETROSPECTIVE COHORT STUDY OF TRIPTANS, BETA-BLOCKERS, AND COMBINATION THERAPY
Feb 25, 2026, 14:42 PM -
REAL-WORLD ADHERENCE TO GLP-1RA AND DUAL GIP-GLP-1RA AMONG COMMERCIALLY INSURED US PATIENTS WITH TYPE 2 DIABETES AND OBESITY
Feb 25, 2026, 14:42 PM -
REAL-WORLD COMPARISON OF OLANZAPINE/SAMIDORPHAN VS OLANZAPINE: AN ASSESSMENT OF TREATMENT PATTERNS AND ACUTE CARE EVENTS AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
Feb 25, 2026, 14:42 PM -
CLINICAL EFFECTIVENESS OF 3D PRINTED ORTHOPAEDIC IMPLANTS COMPARED WITH CONVENTIONAL IMPLANTS: A SYSTEMATIC REVIEW AND METAANALYSIS
Feb 25, 2026, 14:42 PM -
UNDERSTANDING THE DRIVERS OF VALUE IN COST-EFFECTIVENESS ANALYSIS
Feb 25, 2026, 14:42 PM -
REAL-WORLD ROS1 TESTING IN FIRST-LINE NON-SMALL CELL LUNG CANCER
Feb 25, 2026, 14:42 PM -
REPORTING OF STUDY DETAILS IN ABSTRACTS: INFORMATIVE FOR ARTIFICIAL INTELLIGENCE (AI) OR UNDERWHELMING?
Feb 25, 2026, 14:42 PM -
VALIDATION OF THE REAL-Q (REAL-WORLD EVALUATION ASSESSMENT LIST FOR QUALITY) TOOL
Feb 25, 2026, 14:42 PM -
SOURCES OF BIAS IN PATIENT-REPORTED OUTCOME (PRO) DATA COLLECTION: EVIDENCE GAPS IN THEIR IMPACT ON DATA QUALITY
Feb 25, 2026, 14:42 PM
